-Menarini Group anuncia colaboración con VisualDx para ayudar a identificar a personas que podrían tener neoplasia blástica de células dendríticas plasmocitoides (BPDCN) BPDCN es una neoplasia hematológica agresiva con un pronóstico históricamente desfavorable. VisualDx es un sistema de…
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.